X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
Details:
With the acquisition of Teralithe 250mg, divisible tablet and Teralithe LP 400mg, prolonged-release tablet (lithium carbonate), by Laboratoires DELBERT reinforces the strategy to ensure safe and continuous availability of Medications to patients and reinforce CNS portfolio.
Lead Product(s): Lithium Carbonate
Therapeutic Area: Psychiatry/Psychology Product Name: Teralithe
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Laboratoires DELBERT
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition April 25, 2022
Iran Expo
Not Confirmed
Contact Supplier
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
